Activist investor Elliott builds stake in life-science tools supplier Bio-Rad Laboratories, WSJ reports
18/05/2026 01:31
May 17 (Reuters) - Activist investor Elliott Investment Management has built a sizable stake in Bio-Rad Laboratories BIO.N and plans to push the supplier of life-science tools and diagnostics products to boost its underperforming stock price, the Wall Street Journal reported on Sunday. Reuters could not immediately verify the WSJ report. (Reporting by Rishabh Jaiswal in Bengaluru; Editing by Subhranshu Sahu) ((rishabh.jaiswal@thomsonreuters.com; +91 9916719147))
Recent news on Bio-Rad Laboratories
See all newsBio-Rad Laboratories, Inc. reports results for the quarter ended June 30 - Earnings Summary
Brief: Bio-Rad Laboratories On July 31, Initiated Restructuring Plan - SEC Filing
Bio-Rad Q2 revenue beats analyst estimates on clinical diagnostics growth
Brief: Bio-Rad Q2 Net Income USD 371.4 Million
Activist investors make bigger push for campaigns in H1, seek more M&A